|
1
|
Namiecińska M, Marciniak K and Nowak JZ:
VEGF as an angiogenic, neurotrophic, and neuroprotective factor.
Postepy Hig Med Dosw (Online). 59:573–583. 2005.(In Polish).
|
|
2
|
Anai S, Sakamoto N, Sakai Y, Tanaka M,
Porvasnik S, Urbanek C, Cao W, Goodison S and Rosser CJ: Dual
targeting of Bcl-2 and VEGF: a potential strategy to improve
therapy for prostate cancer. Urol Oncol. 29:421–429. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tao J, Tu YT, Huang CZ, Feng AP, Wu Q,
Lian YJ, Zhang LX, Zhang XP and Shen GX: Inhibiting the growth of
malignant melanoma by blocking the expression of vascular
endothelial growth factor using an RNA interference approach. Br J
Dermatol. 153:715–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rhee J and Hoff PM: Angiogenesis
inhibitors in the treatment of cancer. Expert Opin Pharmacother.
6:1701–1711. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sitohy B, Nagy JA and Dvorak HF:
Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer
Res. 72:1909–1914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chakraborty C: Potentiality of small
interfering RNAs (siRNA) as recent therapeutic targets for
gene-silencing. Curr Drug Targets. 8:469–482. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McNamara JO II, Andrechek ER, Wang Y,
Viles KD, Rempel RE, Gilboa E, Sullenger BA and Giangrande PH: Cell
type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat
Biotechnol. 24:1005–1015. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du J, Sun Y, Shi QS, Liu PF, Zhu MJ, Wang
CH, Du LF and Duan YR: Biodegradable nanoparticles of mPEG-PLGA-PLL
triblock copolymers as novel non-viral vectors for improving siRNA
delivery and gene silencing. Int J Mol Sci. 13:516–533. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vamer JA and Cheresh DA: Tumor
angiogenesis and the role of vascular cell integrin alphavbeta3.
Important Adv Oncol. 1:69–87. 1996.
|
|
10
|
Eliceiri BP and Cheresh DA: The role of
alphav integrins during angiogenesis: insights into potential
mechanisms of action and clinical development. J Clin Invest.
103:1227–1230. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng DQ, Woodard AS, Fornaro M, Tallini G
and Languino LR: Prostatic carcinoma cell migration via
alpha(v)beta3 integrin is modulated by a focal adhesion kinase
pathway. Cancer Res. 59:1655–1664. 1999.PubMed/NCBI
|
|
12
|
Li HL, Zheng XZ, Wang HP, Li F, Wu Y and
Du LF: Ultrasound-targeted microbubble destruction enhances
AAV-mediated gene transfection in human RPE cells in vitro and rat
retina in vivo. Gene Ther. 16:1146–1153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carson AR, McTiernan CF, Lavery L, Hodnick
A, Grata M, Leng X, Wang J, Chen X, Modzelewski RA and Villanueva
FS: Gene therapy of carcinoma using ultrasound-targeted microbubble
destruction. Ultrasound Med Biol. 37:393–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shohet RV and Grayburn PA: Potential
bioeffects of ultrasonic destruction of microbubble contrast
agents. J Am Coll Cardiol. 47:1469–1470. 2006.PubMed/NCBI
|
|
15
|
Lai CY, Wu CH, Chen CC and Li PC:
Quantitative relations of acoustic inertial cavitation with
sonoporation and cell viability. Ultrasound Med Biol. 32:1931–1941.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ay T, Havaux X, Van Camp G, Campanelli B,
Gisellu G, Pasque A, Denef JF, Melin JA and Vanoverschelde JL:
Destruction of contrast microbubbles by ultrasound: effects on
myocardial function, coronary perfusion pressure and microvascular
integrity. Circulation. 104:461–466. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie J, Shen Z, Li KC and Danthi N: Tumor
angiogenic endothelial cell targeting by a novel integrin-targeted
nanoparticle. Int J Nanomedicine. 2:479–485. 2007.PubMed/NCBI
|
|
18
|
Lin RY, Dayananda K, Chen TJ, Chen CY, Liu
GC, Lin KL and Wang YM: Targeted RGD nanoparticles for highly
sensitive in vivo integrin receptor imaging. Contrast Media Mol
Imaging. 7:7–18. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mu Y, Li L and Ayoufu G: Experimental
study of the preparation of targeted microbubble contrast agents
carrying urokinase and RGDS. Ultrasonics. 49:676–681. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dayton PA, Pearson D, Clark J, Simon S,
Schumann PA, Zutshi R, Matsunaga TO and Ferrara KW: Ultrasonic
analysis of peptide- and antibody-targeted microbubble contrast
agents for molecular imaging of alphavbeta3-expressing cells. Mol
Imaging. 3:125–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rong W, Wang J, Liu X, Jiang L, Wei F, Hu
X, Han X and Liu Z: Naringin treatment improves functional recovery
by increasing BDNF and VEGF expression, inhibiting neuronal
apoptosis after spinal cord injury. Neurochem Res. 37:1615–1623.
2012. View Article : Google Scholar
|
|
22
|
Ferrari G, Pintucci G, Seghezzi G, Hyman
K, Galloway AC and Mignatti P: VEGF, a prosurvival factor, acts in
concert with TGF-beta1 to induce endothelial cell apoptosis. Proc
Natl Acad Sci USA. 103:17260–17265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fadok VA, Bratton DL, Frasch SC, Warner ML
and Henson PM: The role of phosphatidylserine in recognition of
apoptotic cells by phagocytes. Cell Death Differ. 5:551–562. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen
G, Tang J and Ma D: TFAR19, a novel apoptosis-related gene, cloned
from human leukemia cell line TF-1, could enhance apoptosis of some
tumor cells induced by growth factor withdrawal. Biochem Biophys
Res Commun. 254:203–210. 1999. View Article : Google Scholar
|
|
25
|
Xu L, Chen Y, Song Q, Xu D, Wang Y and Ma
D: PDCD5 interacts with Tip60 and functions as a cooperator in
acetyltransferase activity and DNA damage-induced apoptosis.
Neoplasia. 11:345–354. 2009.PubMed/NCBI
|
|
26
|
Zhuge C, Chang Y, Li Y, Chen Y and Lei J:
PDCD5-regulated cell fate decision after
ultraviolet-irradiation-induced DNA damage. Biophys J.
101:2582–2591. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Sun R, Han W, Zhang Y, Song Q, Di
C and Ma D: Nuclear translocation of PDCD5 (TFAR19): an early
signal for apoptosis? FEBS Lett. 509:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang J, Wang N, Guan Z and Houshan LV:
Programmed cell death 5 factor enhances triptolide-induced
fibroblast-like synoviocyte apoptosis of rheumatoid arthritis.
Artif Cells Blood Substit Immobil Biotechnol. 38:38–42. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Li X, Wang L, Ding P, Zhang Y, Han
W and Ma D: An alternative form of paraptosis-like cell death,
triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell
Sci. 117:1525–1532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feril LB Jr, Kondo T, Zhao QL, Ogawa R,
Tachibana K, Kudo N, Fujimoto S and Nakamura S: Enhancement of
ultrasound-induced apoptosis and cell lysis by echo-contrast
agents. Ultrasound Med Biol. 29:331–337. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Honda H, Zhao QL and Kondo T: Effects of
dissolved gases and an echo contrast agent on apoptosis induced by
ultrasound and its mechanism via the mitochondria-caspase pathway.
Ultrasound Med Biol. 28:673–682. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Skyba DM, Price RJ, Linka AZ, Skalak TC
and Kaul S: Direct in vivo visualization of intravascular
destruction of microbubbles by ultrasound and its local effects on
tissue. Circulation. 98:290–293. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miller MW, Everbach EC, Cox C, Knapp RR,
Brayman AA and Sherman TA: A comparison of hemolytic potential of
Optison and Albunex in whole human blood in vitro: acoustic
pressure, ultrasound frequency, donor and passive cavitation
detection considerations. Ultrasound Med Biol. 27:709–721. 2001.
View Article : Google Scholar
|
|
34
|
Danhier F, Pourcelle V, Marchand-Brynaert
J, Jérôme C, Feron O and Préat V: Targeting of tumor endothelium by
RGD-grafted PLGA-nanoparticles. Methods Enzymol. 508:157–175. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu P, Qi X, Sun Y, Wang H, Li Y and Duan
Y: RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast
cancer xenografts in vivo. J Nanosci Nanotechnol. 11:10760–10764.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karshafian R, Samac S, Bevan PD and Burns
PN: Microbubble mediated sonoporation of cells in suspension:
clonogenic viability and influence of molecular size on uptake.
Ultrasonics. 50:691–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
